How to correct the market for children’s cancer drugs - Nature Medicine

  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 53%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

How to correct the market for children’s cancer drugs The development of pediatric cancer drugs is vastly underfunded compared with that for adults, but legislation can correct market failures. ChildhoodCancerAwarenessMonth CancerTherapy

My son, Jacob, could have been in one of those photos. At eight, Jacob was a boy whose passions were singing 1990s rock songs and playing baseball. One morning, he began to experience nausea and headaches.

Soon after, our world fell apart as Jacob was diagnosed with medulloblastoma, a pediatric cancer. I was stunned by the diagnosis, and I was shocked to learn that the cancer therapies available to treat Jacob were over 40 years old, and were unlikely to work. Jacob died two years later.

 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 451. in İD

Indonesia Berita Terbaru, Indonesia Berita utama